Zordoky Beshay N. M., Robertson Ian M., Dyck Jason R. B.
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2015
Abstract
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease is still rising. Therefore, new lines of medications are needed to treat the growing population of patients with cardiovascular disease. Although the majority of the existing pharmacotherapies for cardiovascular disease are synthesized molecules, natural compounds, such as resveratrol, are also being tested. Resveratrol is a non-flavonoid polyphenolic compound, which has several biological effects. Preclinical studies have provided convincing evidence that resveratrol has beneficial effects in animal models of hypertension, atherosclerosis, stroke, ischemic heart disease, arrhythmia, chemotherapy-induced cardiotoxicity, diabetic cardiomyopathy, and heart failure. Although not fully delineated, some of the beneficial cardiovascular effects of resveratrol are mediated through activation of silent information regulator 1 (SIRT1), AMP-activated protein kinase (AMPK), and endogenous anti-oxidant enzymes. In addition to these pathways, the anti-inflammatory, anti-platelet, insulin-sensitizing, and lipid-lowering properties of resveratrol contribute to its beneficial cardiovascular effects. Despite the promise of resveratrol as a treatment for numerous cardiovascular diseases, the clinical studies for resveratrol are still limited. In addition, several conflicting results from trials have been reported, which demonstrates the challenges that face the translation of the exciting preclinical findings to humans. Herein, we will review much of the preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular disease and provide information about the physiological and molecular signaling mechanisms involved. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
Keywords
Cardiovascular disease; Resveratrol.
Copyright © 2014 Elsevier B.V. All rights reserved.
| PMID: | 25451966 |
|---|---|
| DOI: | 10.1016/j.bbadis.2014.10.016 |
| Category: | Cardiovascular Support |
The best supplements with Resveratrol in Cardiovascular Support category:
- Natural Resveratrol, 200 mg, 120 Veg Capsules (Now Foods) - Resveratrol is a polyphenol naturally found in the skin of red grapes, certain berries, and other plants. It contains among others: Resveratrol.
- Vitabase - Enfūz (Advanced) - Enfūz Advanced is a complete nutritional supplement program designed to meet your basic nutritional needs. It contains among others: Resveratrol.
- Varicorin - Varicorin is the ideal solution for people suffering from varicose veins, spider veins or swollen legs. It contains among others: Resveratrol.
Articles similar to "Preclinical and Clinical Evidence for the Role of Resveratrol in the Treatment of Cardiovascular Diseases."
- The significance of Resveratrol for Cardiovascular Support: Cardiovascular Protective Effects and Clinical Applications of Resveratrol. (Resveratrol is a naturally occurring phenol that is generated by plant species following injury or attack by bacterial and fungal pathogens...)
- The role of Resveratrol in Cardiovascular Support: Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. (Resveratrol (RV) is a natural non-flavonoid polyphenol and phytoalexin produced by a number of plants such as peanuts, grapes, red wine and berries...)
- The impact of Resveratrol on Cardiovascular Support: Resveratrol and Cardiovascular Diseases. (The increased incidence of cardiovascular diseases (CVDs) has stimulated research for substances that could improve cardiovascular health...)
- The significance of Resveratrol for Cardiovascular Support: Resveratrol and Vascular Function. (Resveratrol increases the production of nitric oxide (NO) in endothelial cells by upregulating the expression of endothelial NO synthase (eNOS), stimulating eNOS enzymatic activity, and preventing eNOS uncoupling...)
Previous article
Health Effects of Resveratrol: Results From Human Intervention Trials.